EP Patent

EP4151637A1 — Gadolinium bearing pcta-based contrast agents

Assigned to Bracco Imaging SpA · Expires 2023-03-22 · 3y expired

What this patent protects

The present invention relates to processes for the preparation of an amide derivative of Gd(PCTA-tris-glutaric acid), or of an isomeric mixture of an amide derivative of Gd(PCTAtris-glutaric acid), as well as the use of such amide derivative as contrast agents.

USPTO Abstract

The present invention relates to processes for the preparation of an amide derivative of Gd(PCTA-tris-glutaric acid), or of an isomeric mixture of an amide derivative of Gd(PCTAtris-glutaric acid), as well as the use of such amide derivative as contrast agents.

Drugs covered by this patent

Patent Metadata

Patent number
EP4151637A1
Jurisdiction
EP
Classification
—
Expires
2023-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Bracco Imaging SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.